Endo Pharmaceuticals

NCT01697384

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

NCT01394263

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

NCT00904280

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

NCT00904449

Open Label Assessment of Long-Term Safety and Utility

NCT00644033

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

NCT00904085

Post-operative Efficacy and Safety Study

NCT00911287

Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

NCT00260429

Collagenase in the Treatment of Dupuytrens Disease

NCT00911261

Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain

NCT01035983

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches

NCT00226395

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

NCT00779103

Histrelin Subcutaneous Implant in Children With Central Precocious Puberty

NCT00226421

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

NCT00475514

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

NCT00225797

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

NCT00262106

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

NCT00266214

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

NCT00467870

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

NCT00426985

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

NCT00522431

A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone

NCT00528606

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture

NCT00533273

Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

NCT00528840

Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

NCT00528424

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

NCT00574860

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

NCT00765323

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

NCT00765856

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

NCT00801398

Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.

NCT01221597

Study of AA4500 in the Treatment of Peyronie's Disease

NCT01206907

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

NCT01221623

Study of AA4500 in the Treatment of Peyronie's Disease

NCT01228071

Time to Eugonadal Range, Time to Steady State and Drying Time

NCT01243411

A Study of AA4500 in Men With Peyronie's Disease

NCT01210352

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

NCT01295060

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

NCT01310803

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

NCT01407068

Administration of Two Injections for Multiple Dupuytren's Contractures

NCT01674634

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

NCT01685437

A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease

NCT04681027

Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children

NCT02267460

An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease

NCT02687451

Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

NCT03428750

Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

NCT03446781

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

NCT03526549

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

NCT04170296

Real World CCH Study in Adult Females With Cellulite

NCT05254457

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

NCT06151197

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)